Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02722512 · ClinicalTrials.gov registry record · Phase 1
Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine
A Phase 1 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- Terminated
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT02722512: Clinical Trial Phase 1 study, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
NCT02722512 is a Phase 1 study that was terminated before completion, run by Ann & Robert H Lurie Children's Hospital of Chicago. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02722512, a Phase 1 study, was terminated before completion, sponsored by Ann & Robert H Lurie Children's Hospital of Chicago.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine is an feasible and safe treatment for pediatric patients with newly-diagnosed High-Grade Gliomas or recurrent, resectable High-Grade Gliomas and Ependymomas.
Interventions
- RADIATION Radiation
- PROCEDURE Tumor Resection
- BIOLOGICAL Heat Shock Protein Peptide Complex-96 (HSPPC-96)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2016-07 |
| Est. Completion | 2019-11-13 |
| Phase | Phase 1 |
Why NCT02722512 stopped before completion
NCT02722512 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 3 interventions - of which Radiation is the first listed.
NCT02722512 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02722512 about?
NCT02722512 is a clinical study titled "Trial of Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine". The purpose of this study is to determine whether Heat Shock Protein Peptide Complex-96 (HSPPC-96) Vaccine is an feasible and safe treatment for pediatric patients with newly-diagnosed High-Grade Gliomas or recurrent, resectable High-Grade Gliomas and Ependymomas.
What is the current status of trial NCT02722512?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2016-07. Estimated completion is 2019-11-13.
What interventions are being tested in trial NCT02722512?
The interventions under investigation include: Radiation (RADIATION), Tumor Resection (PROCEDURE), Heat Shock Protein Peptide Complex-96 (HSPPC-96) (BIOLOGICAL).
Who is sponsoring clinical trial NCT02722512?
This trial is sponsored by Ann & Robert H Lurie Children's Hospital of Chicago, which has 159 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02722512's enrollment target sits among peer trials
10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia